These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

291 related items for PubMed ID: 18619957

  • 21. Simvastatin potentiates tumor necrosis factor alpha-mediated apoptosis of human vascular endothelial cells via the inhibition of the geranylgeranylation of RhoA.
    Tang D, Park HJ, Georgescu SP, Sebti SM, Hamilton AD, Galper JB.
    Life Sci; 2006 Sep 05; 79(15):1484-92. PubMed ID: 16740276
    [Abstract] [Full Text] [Related]

  • 22. Simvastatin Increases Fibulin-2 Expression in Human Coronary Artery Smooth Muscle Cells via RhoA/Rho-Kinase Signaling Pathway Inhibition.
    Serra N, Rosales R, Masana L, Vallvé JC.
    PLoS One; 2015 Sep 05; 10(7):e0133875. PubMed ID: 26207907
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Simvastatin inhibits glucose-stimulated vascular smooth muscle cell migration involving increased expression of RhoB and a block of Ras/Akt signal.
    Chan KC, Wu CH, Huang CN, Lan KP, Chang WC, Wang CJ.
    Cardiovasc Ther; 2012 Apr 05; 30(2):75-84. PubMed ID: 20946258
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. 2-methoxyestradiol inhibits atorvastatin-induced rounding of human vascular smooth muscle cells.
    Yin H, Gui Y, Zheng XL.
    J Cell Physiol; 2010 Mar 05; 222(3):556-64. PubMed ID: 19937728
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. ROCK pathway participates in the processes that 15-hydroxyeicosatetraenoic acid (15-HETE) mediated the pulmonary vascular remodeling induced by hypoxia in rat.
    Ma J, Liang S, Wang Z, Zhang L, Jiang J, Zheng J, Yu L, Zheng X, Wang R, Zhu D.
    J Cell Physiol; 2010 Jan 05; 222(1):82-94. PubMed ID: 19746421
    [Abstract] [Full Text] [Related]

  • 31. HMG-CoA reductase inhibitor simvastatin mitigates VEGF-induced "inside-out" signaling to extracellular matrix by preventing RhoA activation.
    Xu H, Zeng L, Peng H, Chen S, Jones J, Chew TL, Sadeghi MM, Kanwar YS, Danesh FR.
    Am J Physiol Renal Physiol; 2006 Nov 05; 291(5):F995-1004. PubMed ID: 16774905
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Targeting RhoA/ROCK pathway in pulmonary arterial hypertension.
    Antoniu SA.
    Expert Opin Ther Targets; 2012 Apr 05; 16(4):355-63. PubMed ID: 22449260
    [Abstract] [Full Text] [Related]

  • 34. TMEM16A contributes to angiotensin II-induced cerebral vasoconstriction via the RhoA/ROCK signaling pathway.
    Li RS, Wang Y, Chen HS, Jiang FY, Tu Q, Li WJ, Yin RX.
    Mol Med Rep; 2016 Apr 05; 13(4):3691-9. PubMed ID: 26955761
    [Abstract] [Full Text] [Related]

  • 35. Simvastatin reduces human atrial myofibroblast proliferation independently of cholesterol lowering via inhibition of RhoA.
    Porter KE, Turner NA, O'Regan DJ, Balmforth AJ, Ball SG.
    Cardiovasc Res; 2004 Mar 01; 61(4):745-55. PubMed ID: 14985071
    [Abstract] [Full Text] [Related]

  • 36. Actin cytoskeleton dynamics promotes leptin-induced vascular smooth muscle hypertrophy via RhoA/ROCK- and phosphatidylinositol 3-kinase/protein kinase B-dependent pathways.
    Zeidan A, Paylor B, Steinhoff KJ, Javadov S, Rajapurohitam V, Chakrabarti S, Karmazyn M.
    J Pharmacol Exp Ther; 2007 Sep 01; 322(3):1110-6. PubMed ID: 17562852
    [Abstract] [Full Text] [Related]

  • 37. Simvastatin inhibits NOR-1 expression induced by hyperlipemia by interfering with CREB activation.
    Crespo J, Martínez-González J, Rius J, Badimon L.
    Cardiovasc Res; 2005 Aug 01; 67(2):333-41. PubMed ID: 16005304
    [Abstract] [Full Text] [Related]

  • 38. Simvastatin inhibits TNFalpha-induced invasion of human cardiac myofibroblasts via both MMP-9-dependent and -independent mechanisms.
    Turner NA, Aley PK, Hall KT, Warburton P, Galloway S, Midgley L, O'Regan DJ, Wood IC, Ball SG, Porter KE.
    J Mol Cell Cardiol; 2007 Aug 01; 43(2):168-76. PubMed ID: 17560598
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Atorvastatin but not elocalcitol increases sildenafil responsiveness in spontaneously hypertensive rats by regulating the RhoA/ROCK pathway.
    Fibbi B, Morelli A, Marini M, Zhang XH, Mancina R, Vignozzi L, Filippi S, Chavalmane A, Silvestrini E, Colli E, Adorini L, Vannelli GB, Maggi M.
    J Androl; 2008 Aug 01; 29(1):70-84. PubMed ID: 17699803
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.